Clinical Trials Logo

HIV Vaccine clinical trials

View clinical trials related to HIV Vaccine.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05604209 Recruiting - HIV-1-infection Clinical Trials

Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3m4 in Persons With HIV-1 Suppressed on ART

CM HIV-Core008
Start date: October 13, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate whether intramuscular (IM) vaccination with C62-M4 or C1C62-M3M4 in persons with HIV-1 (PWH) on suppressive antiretroviral therapy (ART) will be safe and increase HIV-1-specific T cell responses targeting conserved regions of HIV-1.